IDAI vs SRPT · rev $3.1M vs rev $1.13B
Trust Stamp Inc (IDAI) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Trust Stamp Inc (IDAI) is a software - application company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported IDAI revenue for 2025-12-31 was $3.1M. Net income was -$8.3M. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. IDAI currently screens at market cap $10.9M.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
IDAI currently screens at market cap $10.9M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the IDAI and SRPT stock pages for the full models.
Not investment advice.